| ₹ crore | Q1 FY27 | Year before | Change |
|---|---|---|---|
| Revenue | 386 | — | — |
| EBITDA | 42.5 | — | — |
| EBITDA margin | 11.0% | — | — |
| Profit before tax | 35.4 | — | — |
| Net profit | 26.4 | — | — |
| EPS | ₹5.67 | — | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast close | FY26Mar 2026 |
|---|
| 2,049 | — | |
| 168 | 168 | |
| −1.4 | −1.4 | |
| 260 | 260 | |
| 2,140 | — | |
| 1,517 | 1,517 | |
| 185 | 185 | |
| 12.2% | 12.2% | |
| 155 | 155 | |
| 94.7 | 94.7 | |
| 6.2% | 6.2% | |
| −₹0.68 | −₹0.68 | |
| 59.4 | 59.4 | |
| −77.2 | −77.2 | |
| −17.9 | −17.9 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY26 31/03/2026 | Current last close | |
|---|---|---|---|
| Market Capitalization | — | 2,048.9 | |
| - Cash, Equiv & ST Investments | 167.5 | 167.5 | |
| + Minority Interest | -1.4 | -1.4 | |
| + Total Debt | 260.4 | 260.4 | |
| Enterprise Value | — | 2,140.4 | |
| Revenue | 1,517.1 | 1,517.1 | |
| EBITDA | 185.1 | 185.1 | |
| Margin % | 12.20 | 12.20 | |
| EBIT | 154.8 | 154.8 | |
| Net Income | 94.7 | 94.7 | |
| Margin % | 6.24 | 6.24 | |
| EPS, Adj (current shares) | -0.68 | -0.68 | |
| Cash from Operations | 59.4 | 59.4 | |
| Capital Expenditures | -77.2 | -77.2 | |
| Free Cash Flow | -17.9 | -17.9 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
GSP Crop Science (NSE: GSPCROP) had a market capitalisation of ₹2,015 crore at the 30 October 2026 close (₹433.05 a share) and a price-to-book ratio of 2.61. In FY26 its consolidated net loss was ₹3.2 crore on revenue of ₹1,517 crore; in Q1 FY27 (April–June 2026) it was ₹26.4 crore. Its debt-to-equity ratio was 0.34 on 31 March 2026. Promoters held 71.73% of the shares on 30 September 2026.
GSP Crop Science's price-to-book (PB) ratio is 2.61 at the 30 October 2026 close: a market capitalisation of ₹2,015 crore divided by shareholders' equity (book value) of ₹772 crore on 31 March 2026. That is a book value of ₹165.88 per share against a share price of ₹433.05.
GSP Crop Science's net worth — shareholders' equity in its consolidated balance sheet — was ₹772 crore on 31 March 2026. Its market value is a different figure: a market capitalisation of ₹2,015 crore at the 30 October 2026 close.
GSP Crop Science's book value per share was ₹165.88 on 31 March 2026: shareholders' equity of ₹772 crore divided by the 4.65 crore shares in issue. The share price at the 30 October 2026 close was ₹433.05.
GSP Crop Science's market capitalisation was ₹2,015 crore at the 30 October 2026 close: 4.65 crore shares at ₹433.05 each.
In 2026, GSP Crop Science has declared one dividend: ₹1 with record date 11 September 2026.
Promoters held 71.73% of GSP Crop Science on 30 September 2026, unchanged from the previous quarter, according to the shareholding pattern filed with NSE.
No. GSP Crop Science had borrowings of ₹260 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.34. Its cash and current investments were ₹184 crore, so its net debt was ₹76 crore.
GSP Crop Science's debt-to-equity ratio was 0.34 on 31 March 2026: borrowings of ₹260 crore against total equity of ₹770 crore.
In FY26, GSP Crop Science generated ₹59.4 crore of cash from operations and spent ₹77.2 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹17.9 crore.
GSP Crop Science's basic earnings per share (EPS) were ₹24.93 in FY26.
In FY26 (April 2025–March 2026), GSP Crop Science's consolidated net loss was ₹3.2 crore, on revenue from operations of ₹1,517 crore.
GSP Crop Science has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
On 30 September 2026, GSP Crop Science's shares were held by promoters 71.73%, foreign portfolio investors (FII/FPI) 9.55% and retail and other non-institutional investors 18.73%.
GSP Crop Science's latest results are for Q1 FY27 (April–June 2026), filed on 11 August 2026: consolidated net profit ₹26.4 crore; revenue from operations ₹386 crore.
On FY26 consolidated figures, against Bhagiradha Chemicals & Industries, Bharat Rasayan and NACL Industries: GSP Crop Science's operating margin of 10.2% is the second highest of the four (Bhagiradha Chemicals & Industries 6.8%, Bharat Rasayan 13.9%, NACL Industries 4.5%; peer average 8.4%).
In FY26, GSP Crop Science earned net profit of ₹3.2 crore on revenue of ₹1,517 crore, against ₹18.2 crore on ₹536 crore for Bhagiradha Chemicals & Industries. GSP Crop Science's operating margin was 10.2% (Bhagiradha Chemicals & Industries 6.8%). At the 30 October 2026 close, GSP Crop Science's market capitalisation was ₹2,015 crore against ₹2,533 crore for Bhagiradha Chemicals & Industries.
From GSP Crop Science's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.